Ista petitions FDA over eye drug label

03/6/2011 | Reuters

Ista Pharmaceuticals sent a petition asking the FDA to reject any generic version's application for the withdrawn twice-daily eye medicine Xibrom that uses the original labeling. Ista said any generic's label should include a reference to the option of the once-daily dose.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA